Concepedia

Publication | Open Access

Treatment of COVID‐19 patients with the anti‐CD6 antibody itolizumab

DOIFull Paper Access

20

Citations

21

References

2020

Year

Armando Caballero, Lázaro Manuel Filgueira, J. R. Betancourt, Naivy Sánchez, Carlos Hidalgo, Alberto Ramírez, Alejandro Gallego Martínez, Rolando E Despaigne, Alberto Escalona, Henrry Diaz,
Clinical & Translational Immunology

Abstract

The opportune administration of itolizumab might interrupt the hyperinflammatory cascade and prevent COVID-19 morbidity and mortality.

References

YearCitations

Page 1